We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
23 hedge funds and large institutions have $51.7M invested in Fate Therapeutics in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
5% more funds holding
Funds holding: 22 → 23 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $52.6M → $51.7M (-$900K)
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
10
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$880K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$74.2K |
| 3 |
Goldman Sachs
New York
|
-$45.3K |
| 4 |
Morgan Stanley
New York
|
-$22.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.51K |